SCHEMBL4717795

SCHEMBL4717795

CCOC(=O)c1cnc(N(C)C)nc1O[C@H]1CC[C@H](N)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
HSD17B10 Q99714 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.41
JUN P05412 2/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
DYRK1A Q13627 2/20 0.41
HSP90AA1 P07900 1/20 0.39
HPGD P15428 1/20 0.39
CSNK1D P48730 2/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
KDM4E B2RXH2 2/20 0.39
TP53 P04637 2/20 0.38
ALOX15 P16050 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4717794 1.00 ALDH1A1 (0.55) ALDH1A1HSD17B10SMN1; SMN2JUNNFKB1
Hydrochloric Acid SCHEMBL4711068 0.81 KMT2A (0.52) ALDH1A1SMN1; SMN2JUNNFKB1NFKB2
Hydrochloric Acid SCHEMBL4711066 0.81 KMT2A (0.52) ALDH1A1SMN1; SMN2JUNNFKB1NFKB2
SCHEMBL4711781 0.81 PIK3CD (0.43) ALDH1A1HSD17B10SMN1; SMN2JUNNFKB1
SCHEMBL4711783 0.81 PIK3CD (0.43) ALDH1A1HSD17B10SMN1; SMN2JUNNFKB1
SCHEMBL1900150 0.80 ALDH1A1 (0.60) ALDH1A1HSD17B10SMN1; SMN2JUNNFKB1
SCHEMBL14590440 0.79 ALDH1A1 (0.58) ALDH1A1HSD17B10SMN1; SMN2JUNNFKB1
SCHEMBL29652040 0.76 HSP90AA1 (0.54) ALDH1A1SMN1; SMN2NFKB1NFKB2RELA
SCHEMBL22835196 0.76 HSP90AA1 (0.54) ALDH1A1SMN1; SMN2NFKB1NFKB2RELA
SCHEMBL1015157 0.76 CSNK1D (0.43) ALDH1A1SMN1; SMN2JUNNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1325910-B1 ALIPHATIC NITROGENOUS FIVE-MEMBERED RING COMPOUNDS MITSUBISHI TANABE PHARMA CORP (JP) 2008-09-17 EP disclosed
US-7160877-B2 Aliphatic nitrogen-containing 5-membered ring compound TANABE SEIYAKU CO., LTD. (JP) 2007-01-09 US disclosed
US-6849622-B2 Aliphatic nitrogenous five-membered ring compounds TANABE SEIYAKU CO., LTD. (JP) 2005-02-01 US disclosed
US-20040229926-A1 Aliphatic nitrogen - containing 5 - membered ring compound TANABE SEIYAKU CO., LTD. 2004-11-18 US disclosed
US-20040063935-A1 Aliphatic nitrogenous five-membered ring compounds TANABE SEIYAKU CO., LTD. (JP) 2004-04-01 US disclosed
EP-1325910-A1 ALIPHATIC NITROGENOUS FIVE-MEMBERED RING COMPOUNDS TANABE SEIYAKU CO., LTD. (JP) 2003-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063935-A1 Aliphatic nitrogenous five-membered ring compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SCN5A, CYP11B1 ALDH1A1 1113/4885HSD17B10 394/4885SMN1; SMN2 2153/4885
US-20040229926-A1 Aliphatic nitrogen - containing 5 - membered ring compound H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP11B1, CYP11B2 ALDH1A1 715/4885HSD17B10 379/4885SMN1; SMN2 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.